↓ Skip to main content

The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study

Overview of attention for article published in Frontiers in oncology, May 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study
Published in
Frontiers in oncology, May 2021
DOI 10.3389/fonc.2021.642768
Pubmed ID
Authors

Helga Tryggvadottir, Emma Sandén, Sofie Björner, Alessandra Bressan, Maria Ygland Rödström, Somayeh Khazaei, Dean P. Edwards, Björn Nodin, Karin Jirström, Karolin Isaksson, Signe Borgquist, Helena Jernström

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 14%
Student > Postgraduate 2 9%
Other 1 5%
Lecturer 1 5%
Professor 1 5%
Other 3 14%
Unknown 11 50%
Readers by discipline Count As %
Medicine and Dentistry 3 14%
Biochemistry, Genetics and Molecular Biology 2 9%
Nursing and Health Professions 1 5%
Economics, Econometrics and Finance 1 5%
Agricultural and Biological Sciences 1 5%
Other 2 9%
Unknown 12 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 May 2021.
All research outputs
#23,011,330
of 25,655,374 outputs
Outputs from Frontiers in oncology
#16,227
of 22,758 outputs
Outputs of similar age
#394,101
of 458,902 outputs
Outputs of similar age from Frontiers in oncology
#817
of 1,307 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,758 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 458,902 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,307 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.